Marc Nash - 15 Mar 2024 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role: SVP Operations and R&D
Signature: By: John L Brottem For: Marc Nash
Issuer symbol: OM
Transactions as of: 15 Mar 2024
Net transactions value: -$5,093
Form type: 4
Filing time: 15 Mar 2024, 18:40:49 UTC
Previous filing: 16 Feb 2024
Next filing: 17 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OM	Common Stock	Sale	$5,093	-2,391	-0.98%	$2.13	242,510	15 Mar 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 6,399 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).

Content

Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 6,399 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).